跳转到主要内容
主页 / 资源 / 会议 / 2022 年基因治疗免疫原性

2022 年基因治疗免疫原性

Gene Therapy Immunogenicity 2022
演讲嘉宾

We are excited to be presenting at this conference!

Biosimulation Model-informed Gene Therapy Development: Predicting Human Dose and Immunogenicity

Piet van der Graaf, PharmD, PhD

|

高级副总裁,定量系统药理学部

Regulatory-ready IG simulator developed in consortium with eight pharmaceutical companies, now licensed by FDA | Applied to gene therapy for predicting human dose from pre-clinical data, to translational phases, and through clinical development | Case studies highlighting application to various modalities: AAV, mRNA and gene editing

沪ICP备2022021526号

Powered by Translations.com GlobalLink OneLink Software